scholarly journals LOCAL ACTIVATION OF GLUCOCORTICOID SIGNALING IN UTERINE FIBROID CELLS DRIVES GROWTH

2021 ◽  
Vol 116 (3) ◽  
pp. e419-e420
Author(s):  
Tanya L. Glenn ◽  
Erin Silva ◽  
Pablo Suarez ◽  
Clare Flannery ◽  
Shannon Whirledge
Keyword(s):  
Uterine Fibroid ◽  
Local Activation ◽  
Glucocorticoid Signaling

Disruption of mesenchymal glucocorticoid signaling attenuates embryonic lung development and results in post natal lethality in mice

2013 ◽  
pp. 1-1
Author(s):  
Rowan Hardy ◽  
Aiqing Li ◽  
Shihani Stoner ◽  
Jan Tuckermann ◽  
Markus Seibel ◽  
...  
Keyword(s):  
Lung Development ◽  
Embryonic Lung ◽  
Glucocorticoid Signaling

Monitoring glucocorticoid signaling and circadian clock function with transgenic zebrafish reporter lines

2013 ◽  
pp. 1-1
Author(s):  
Benjamin D Weger ◽  
Meltem Weger ◽  
Nicolas Diotel ◽  
Michael Nusser ◽  
Sepand Rastegar ◽  
...  
Keyword(s):  
Circadian Clock ◽  
Transgenic Zebrafish ◽  
Glucocorticoid Signaling

Women’s Infertility - A Ayurvedic thought

2017 ◽  
Vol 2 (4) ◽  
Author(s):  
Sonalika Hiremath ◽  
Santhosh Kumar S. ◽  
Sridevi Swamy
Keyword(s):  
Uterine Fibroid ◽  
Poor Quality ◽  
The State ◽  
Full Term ◽  
Female Infertility ◽  
Cervical Canal ◽  
Fallopian Tubes ◽  
Structural Problems ◽  
Hormonal Imbalance ◽  
Males And Females

Infertility primarily refers to the biological inability of a person to contribute to conception. In women, it may also refer to the state when she is not able to carry a pregnancy to its full term. Female infertility is caused due to structural problems like blocked Fallopian tubes, defect in cervical canal, uterine fibroid or polyps. Hormonal imbalance leading .ovulation problems too can cause infertility. From Ayurvedic perspectives, Shukra Dhatu can get affected by various physical, mental causes and even by serious diseases. Poor quality Shukra Dhatu can cause infertility in males and females.

scholarly journals Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Claudia Haberland ◽  
Anna Filonenko ◽  
Christian Seitz ◽  
Matthias Börner ◽  
Christoph Gerlinger ◽  
...  
Keyword(s):  
Uterine Fibroid ◽  
Full Range ◽  
Intraclass Correlation ◽  
Phase Iii ◽  
Measurement Properties ◽  
Retest Reliability ◽  
Response Options ◽  
Patient Global Impression ◽  
Patient Reported ◽  
Test Retest Reliability

Abstract Background To evaluate the psychometric and measurement properties of two patient-reported outcome instruments, the menstrual pictogram superabsorbent polymer-containing version 3 (MP SAP-c v3) and Uterine Fibroid Daily Bleeding Diary (UF-DBD). Test-retest reliability, criterion, construct validity, responsiveness, missingness and comparability of the MP SAP-c v3 and UF-DBD versus the alkaline hematin (AH) method and a patient global impression of severity (PGI-S) were analyzed in post hoc trial analyses. Results Analyses were based on data from up to 756 patients. The full range of MP SAP-c v3 and UF-DBD response options were used, with score distributions reflecting the cyclic character of the disease. Test-retest reliability of MP SAP-c v3 and UF-DBD scores was supported by acceptable intraclass correlation coefficients when stability was defined by the AH method and Patient Global Impression of Severity (PGI-S) scores (0.80–0.96 and 0.42–0.94, respectively). MP SAP-c v3 and UF-DBD scores demonstrated strong and moderate-to-strong correlations with menstrual blood loss assessed by the AH method. Scores increased in monotonic fashion, with greater disease severities, defined by the AH method and PGI-S scores; differences between groups were mostly statistically significant (P < 0.05). MP SAP-c v3 and UF-DBD were sensitive to changes in disease severity, defined by the AH method and PGI-S. MP SAP-c v3 and UF-DBD showed a lower frequency of missing patient data versus the AH method, and good agreement with the AH method. Conclusions This evidence supports the use of the MP SAP-c v3 and UF-DBD to assess clinical efficacy endpoints in UF phase III studies replacing the AH method.

Sign in / Sign up

Export Citation Format

Share Document